254 related articles for article (PubMed ID: 36065644)
1. Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia.
Moon JH; Kim K; Choi SH
Endocrinol Metab (Seoul); 2022 Aug; 37(4):575-586. PubMed ID: 36065644
[TBL] [Abstract][Full Text] [Related]
2. Identification of a small molecule that stabilizes lipoprotein lipase in vitro and lowers triglycerides in vivo.
Larsson M; Caraballo R; Ericsson M; Lookene A; Enquist PA; Elofsson M; Nilsson SK; Olivecrona G
Biochem Biophys Res Commun; 2014 Jul; 450(2):1063-9. PubMed ID: 24984153
[TBL] [Abstract][Full Text] [Related]
3. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.
Sandesara PB; Virani SS; Fazio S; Shapiro MD
Endocr Rev; 2019 Apr; 40(2):537-557. PubMed ID: 30312399
[TBL] [Abstract][Full Text] [Related]
4. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
6. 2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.
Goldberg IJ
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):700-706. PubMed ID: 29419410
[TBL] [Abstract][Full Text] [Related]
7. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Handelsman Y; Shapiro MD
Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia.
Chen PY; Gao WY; Liou JW; Lin CY; Wu MJ; Yen JH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298929
[TBL] [Abstract][Full Text] [Related]
9. Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment.
Chien KL; Lin YL; Wen HC; Lin HP; Yen CT; Lin SW; Kao JT
Pharmacogenomics; 2009 Feb; 10(2):267-76. PubMed ID: 19207029
[TBL] [Abstract][Full Text] [Related]
10. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
[TBL] [Abstract][Full Text] [Related]
11. New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.
Su X; Peng DQ
Lipids Health Dis; 2018 Jan; 17(1):12. PubMed ID: 29334984
[TBL] [Abstract][Full Text] [Related]
12. Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention.
Quispe R; Sweeney T; Varma B; Agarwala A; Michos ED
Curr Atheroscler Rep; 2022 Oct; 24(10):767-778. PubMed ID: 35895246
[TBL] [Abstract][Full Text] [Related]
13. The Importance of Lipoprotein Lipase Regulation in Atherosclerosis.
Kumari A; Kristensen KK; Ploug M; Winther AL
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356847
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy.
Reiner Ž
Korean Circ J; 2018 Dec; 48(12):1097-1119. PubMed ID: 30403015
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-lowering LPL alleles combined with LDL-C-lowering alleles are associated with an additively improved lipoprotein profile.
Ibi D; Blauw LL; Noordam R; Dollé MET; Jukema JW; Rosendaal FR; Christodoulides C; Neville MJ; Koivula R; Rensen PCN; Karpe F; van Dijk KW
Atherosclerosis; 2021 Jul; 328():144-152. PubMed ID: 34053745
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
Takahashi S
J Atheroscler Thromb; 2017 Jun; 24(6):552-559. PubMed ID: 28428482
[TBL] [Abstract][Full Text] [Related]
17. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
[TBL] [Abstract][Full Text] [Related]
18. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians.
Bays H
Drugs Today (Barc); 2008 Mar; 44(3):205-46. PubMed ID: 18536782
[TBL] [Abstract][Full Text] [Related]
19. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in pharmacotherapy for hypertriglyceridemia.
Sahebkar A; Chew GT; Watts GF
Prog Lipid Res; 2014 Oct; 56():47-66. PubMed ID: 25083925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
